Literature DB >> 21763496

HIV-1 replication and latency are regulated by translational control of cyclin T1.

Mainul Hoque1, Raghavendra A Shamanna, Deyu Guan, Tsafi Pe'ery, Michael B Mathews.   

Abstract

Human immunodeficiency virus (HIV) exploits cellular proteins during its replicative cycle and latent infection. The positive transcription elongation factor b (P-TEFb) is a key cellular transcription factor critical for these viral processes and is a drug target. During viral replication, P-TEFb is recruited via interactions of its cyclin T1 subunit with the HIV Tat (transactivator of transcription) protein and TAR (transactivation response) element. Through RNA silencing and over-expression experiments, we discovered that nuclear factor 90 (NF90), a cellular RNA binding protein, regulates P-TEFb expression. NF90 depletion reduced cyclin T1 protein levels by inhibiting translation initiation. Regulation was mediated by the 3' untranslated region of cyclin T1 mRNA independently of microRNAs. Cyclin T1 induction is involved in the escape of HIV-1 from latency. We show that the activation of viral replication by phorbol ester in latently infected monocytic cells requires the posttranscriptional induction of NF90 and cyclin T1, implicating NF90 in protein kinase C signaling pathways. This investigation reveals a novel mechanism of cyclin T1 regulation and establishes NF90 as a regulator of HIV-1 replication during both productive infection and induction from latency.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763496      PMCID: PMC3164259          DOI: 10.1016/j.jmb.2011.03.060

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  90 in total

1.  Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR.

Authors:  L R Saunders; D J Perkins; S Balachandran; R Michaels; R Ford; A Mayeda; G N Barber
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

2.  Differential activation of Tat variants in mitogen-stimulated cells: implications for HIV-1 postintegration latency.

Authors:  Syed M Reza; Mihaela Rosetti; Michael B Mathews; Tsafi Pe'ery
Journal:  Virology       Date:  2003-05-25       Impact factor: 3.616

3.  Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in response to CD28 costimulation.

Authors:  Yuan Pei; Ping Zhu; Yongjun Dang; Jiaxue Wu; Xianmei Yang; Bo Wan; Jun O Liu; Qing Yi; Long Yu
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

4.  Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate.

Authors:  T M Folks; J Justement; A Kinter; S Schnittman; J Orenstein; G Poli; A S Fauci
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

5.  Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines.

Authors:  R Ghose; L Y Liou; C H Herrmann; A P Rice
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Binding properties of newly identified Xenopus proteins containing dsRNA-binding motifs.

Authors:  B L Bass; S R Hurst; J D Singer
Journal:  Curr Biol       Date:  1994-04-01       Impact factor: 10.834

7.  Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90/110 involved in mitotic control.

Authors:  Deyu Guan; Nihal Altan-Bonnet; Andrew M Parrott; Cindy J Arrigo; Quan Li; Mohammed Khaleduzzaman; Hong Li; Chee-Gun Lee; Tsafi Pe'ery; Michael B Mathews
Journal:  Mol Cell Biol       Date:  2008-05-05       Impact factor: 4.272

Review 8.  Protein kinase C: poised to signal.

Authors:  Alexandra C Newton
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

9.  Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).

Authors:  Ya-Lin Chiu; Hong Cao; Jean-Marc Jacque; Mario Stevenson; Tariq M Rana
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Suppression of HIV-1 replication by microRNA effectors.

Authors:  Christine Chable-Bessia; Oussama Meziane; Daniel Latreille; Robinson Triboulet; Alessia Zamborlini; Alexandre Wagschal; Jean-Marc Jacquet; Jacques Reynes; Yves Levy; Ali Saib; Yamina Bennasser; Monsef Benkirane
Journal:  Retrovirology       Date:  2009-03-09       Impact factor: 4.602

View more
  32 in total

Review 1.  Tinkering with translation: protein synthesis in virus-infected cells.

Authors:  Derek Walsh; Michael B Mathews; Ian Mohr
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

2.  Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.

Authors:  M A Rochat; E Schlaepfer; R F Speck
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 3.  Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Virology       Date:  2014-02-22       Impact factor: 3.616

4.  Latency-Reversing Agents Induce Differential Responses in Distinct Memory CD4 T Cell Subsets in Individuals on Antiretroviral Therapy.

Authors:  Marion Pardons; Rémi Fromentin; Amélie Pagliuzza; Jean-Pierre Routy; Nicolas Chomont
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.423

5.  HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo.

Authors:  Andrew Timmons; Emily Fray; Mithra Kumar; Fengting Wu; Weiwei Dai; Cynthia Korin Bullen; Peggy Kim; Carrie Hetzel; Chao Yang; Subul Beg; Jun Lai; Joel L Pomerantz; Steven A Yukl; Janet D Siliciano; Robert F Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

Review 6.  Progress and challenges in the use of latent HIV-1 reactivating agents.

Authors:  Hong-tao Shang; Ji-wei Ding; Shu-ying Yu; Tao Wu; Qiu-li Zhang; Fu-jun Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

7.  Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription.

Authors:  Koen Bartholomeeusen; Koh Fujinaga; Yanhui Xiang; B Matija Peterlin
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

8.  Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells.

Authors:  Sona Budhiraja; Marylinda Famiglietti; Alberto Bosque; Vicente Planelles; Andrew P Rice
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  Cyclophilin B enhances HIV-1 infection.

Authors:  Jason DeBoer; Christian J Madson; Michael Belshan
Journal:  Virology       Date:  2016-01-14       Impact factor: 3.616

Review 10.  HIV-1 endocytosis in astrocytes: a kiss of death or survival of the fittest?

Authors:  Ashok Chauhan; Akshay Tikoo; Jankiben Patel; Arwa Mujahid Abdullah
Journal:  Neurosci Res       Date:  2014-09-08       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.